LRMR

Larimar Therapeutics (LRMR)

Larimar Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LRMR

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	05:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/06/01	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/06/01	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/05/31	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/05/28	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/05/21	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/05/10	05:50	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/05/09	20:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/03/12	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/17	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/15	10:57	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/15	07:08	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/14	22:55	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/14	20:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/14	06:46	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/02/12	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/01/20	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/01/20	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/01/20	06:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2024/01/20	06:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/12/09	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/11/15	03:51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/10/04	05:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/08/14	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/08/11	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/08/10	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/07/26	02:06	Dow Jones News	Larimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 Trial	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/07/25	20:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/07/19	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc
2023/07/19	05:13	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LRMR	Larimar Therapeutics Inc